3 completed, 1 active not recruiting, 1 unknown. 5 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 3, Active not recruiting 1, Unknown 1 |
| Phase 2 | 2 | Completed 2 |
Follow Safety Issues: new trials by email Literature Review of Safety Issues trials Research Report on Safety Issues
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune Thrombocytopenia GP404141, Nplate - Drug Effect, Safety Issues | Phase 3 | Active not recruiting | Geropharm | 160 | 2023-04-04 | 2024-07-11 |
| Trial of Belimumab Combined With Multi-target Induction Therapy in Lupus Nephritis Methylprednisolone Injectable Suspension, Belimumab Injection, Immunosuppressive Agents - Lupus Nephritis, Remission | Phase 3 | Unknown | Nanjing University School of Medicine | 15 | 2023-04-01 | 2023-05-18 |
| ADC189 Tablets on Influenza A Virus Infection/Influenza B Virus Infection 15 mg ADC189, 45 mg ADC189, Placebo - Safety Issues, Effect of Drug | Phase 2 / Phase 3 | Completed | Jiaxing AnDiCon Biotech Co.,Ltd | 749 | 2022-12-07 | 2025-01-21 |
| Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III) Vi-DT Typhoid Conjugate Vaccine, PQed Typhoid Conjugate Vaccine, Vi Polysaccharide Vaccine - Safety Issues, Immunogenicity | Phase 3 | Completed | PT Bio Farma | 3071 | 2020-03-02 | 2022-01-04 |
| Trial of Befizal® 200 mg for the Treatment of Leber Hereditary Optic Neuropathy Béfizal - Safety Issues, Efficacy, Self | Phase 2 / Phase 3 | Completed | Hôpital Necker-Enfants Malades | 14 | 2019-03-26 | 2023-09-22 |
Lupus Nephritis (1)
Autoimmune Diseases (1) · Connective Tissue Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Glomerulonephritis (1) · Immune System Diseases (1) · Kidney Diseases (1) · Lupus Erythematosus, Systemic (1) · Male Urogenital Diseases (1) · Nephritis (1) · Skin and Connective Tissue Diseases (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Bezafibrate (1) · Immunosuppressive Agents (1) · Vi polysaccharide vaccine, typhoid (1) · belimumab (1) · romiplostim (1)
Geropharm (1) · Hôpital Necker-Enfants Malades (1) · Jiaxing AnDiCon Biotech Co.,Ltd (1) · Nanjing University School of Medicine (1) · PT Bio Farma (1)
China (2) · France (1) · Indonesia (1) · Russia (1)
Bernie E Medise, MD (1) · Bulat Bakirov, MD (1) · Dmitry Kirtbaya (1) · Dominique Bremond Gignac, MD PhD (1) · Elena Borisenkova (1) · Galina Salogub (1) · Igor Davydkin (1) · Olga Vinogradova (1) · Zhi-Hong Liu, MD (1)